Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonell Patiño-Escobar

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|June 21, 2023
Overcoming proteasome inhibitor resistance in the immunotherapy eraBonell Patiño-Escobar, Alexis Talbot, Arun P Wiita
Cell Stress|October 31, 2022
Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistanceBonell Patiño-Escobar, Ian D Ferguson, Arun P Wiita
Cureus|May 14, 2020
CD38: From Positive to Negative Expression after Daratumumab TreatmentBonell Patiño-Escobar, Roberto Ramos, Maximo Linares, et al.
Cureus|August 1, 2019
Niemann-Pick Disease: An Approach for Diagnosis in AdulthoodBonell Patiño-Escobar, Maria H Solano, Laura Zarabanda, et al.
Cureus|June 22, 2019
Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of LiteratureHumberto Martinez-Cordero, Bonell Patiño-Escobar, Leonardo J Enciso, et al.
Blood Advances|August 6, 2021
FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myelomaAustin B Bigley, Shanae Spade, Nadia H Agha, et al.
Cell Chemical Biology|July 19, 2022
Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myelomaIan D Ferguson, Yu-Hsiu T Lin, Christine Lam, et al.
Blood Neoplasia|June 2, 2025
Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myelomaPriya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugatesAnil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2023
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple MyelomaAnju Wadhwa, Sinan Wang, Bonell Patiño-Escobar, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|June 21, 2023
Overcoming proteasome inhibitor resistance in the immunotherapy eraBonell Patiño-Escobar, Alexis Talbot, Arun P Wiita
Cell Stress|October 31, 2022
Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistanceBonell Patiño-Escobar, Ian D Ferguson, Arun P Wiita
Cureus|May 14, 2020
CD38: From Positive to Negative Expression after Daratumumab TreatmentBonell Patiño-Escobar, Roberto Ramos, Maximo Linares, et al.
Cureus|August 1, 2019
Niemann-Pick Disease: An Approach for Diagnosis in AdulthoodBonell Patiño-Escobar, Maria H Solano, Laura Zarabanda, et al.
Cureus|June 22, 2019
Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of LiteratureHumberto Martinez-Cordero, Bonell Patiño-Escobar, Leonardo J Enciso, et al.
Blood Advances|August 6, 2021
FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myelomaAustin B Bigley, Shanae Spade, Nadia H Agha, et al.
Cell Chemical Biology|July 19, 2022
Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myelomaIan D Ferguson, Yu-Hsiu T Lin, Christine Lam, et al.
Blood Neoplasia|June 2, 2025
Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myelomaPriya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugatesAnil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2023
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple MyelomaAnju Wadhwa, Sinan Wang, Bonell Patiño-Escobar, et al.
Pageof 2